AVALON PHARMACEUTICALS INC (AVRX) is a publicly traded company in the Unknown sector. Across all available filings, 6 corporate insiders have executed 51 transactions totaling $44.6K, demonstrating a bullish sentiment with $26.9K in net insider flow. The most recent transaction on May 28, 2009 involved a transaction of 23,875 shares valued at $0.
No significant insider buying has been recorded for AVRX in the recent period.
No significant insider selling has been recorded for AVRX in the recent period.
Based on recent SEC filings, insider sentiment for AVRX is bullish with an Insider Alignment Score of 80/100 and a net flow of $26.9K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at AVALON PHARMACEUTICALS INC (AVRX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 6 insiders are actively trading AVRX stock, having executed 51 transactions in the past 90 days. The most active insider is Alan G. Walton (Executive), who has made 9 transactions totaling $103.3K.
Get notified when executives and directors at AVRX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| May 28, 2009 | C. Carter Kenneth | Executive | Disposition | 23,875 | $N/A | $0 | |
| May 28, 2009 | C. Carter Kenneth | Executive | Disposition | 3,750 | $N/A | $0 | |
| May 28, 2009 | Michael Hamilton J. | Executive | Disposition | 2,700 | $N/A | $0 | |
| May 28, 2009 | G. Lorimier Bradley | Executive | Disposition | 8,880 | $N/A | $0 | |
| Apr 1, 2008 | Royston Ivor | Executive | Award | 3,528 | $2.48 | $8.7K | |
| Jan 23, 2008 | C. Carter Kenneth | Executive | Purchase | 100 | $2.49 | $249 | |
| Jan 23, 2008 | C. Carter Kenneth | Executive | Purchase | 500 | $2.49 | $1.2K | |
| Jan 23, 2008 | C. Carter Kenneth | Executive | Purchase | 100 | $2.46 | $246 | |
| Jan 23, 2008 | C. Carter Kenneth | Executive | Purchase | 1,400 | $2.65 | $3.7K | |
| Jan 23, 2008 | C. Carter Kenneth | Executive | Purchase | 164 | $2.60 | $426 | |
| Jan 23, 2008 | C. Carter Kenneth | Executive | Purchase | 1,036 | $2.61 | $2.7K | |
| Jan 23, 2008 | C. Carter Kenneth | Executive | Purchase | 800 | $2.60 | $2.1K | |
| Jan 23, 2008 | C. Carter Kenneth | Executive | Purchase | 100 | $2.54 | $254 | |
| Jan 23, 2008 | C. Carter Kenneth | Executive | Purchase | 632 | $2.48 | $1.6K | |
| Jan 17, 2008 | C. Carter Kenneth | Executive | Sale | 200 | $2.64 | $528 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Award(A) | 26 | $226.0K | 83.5% |
Purchase(P) | 14 | $35.7K | 13.2% |
Sale(S) | 7 | $8.9K | 3.3% |
Disposition(D) | 4 | $0 | 0.0% |
Insiders at AVALON PHARMACEUTICALS INC are accumulating shares at an accelerated pace. With 6 insiders making 51 transactions totaling $35.7K in purchases versus $8.9K in sales, the net buying activity of $26.9K signals strong executive confidence. Alan G. Walton (Executive) leads the buying activity with $103.3K in transactions across all time.